October 24, 2024 11:29 AM EDT
Manufacturing

Lon­za ex­tends con­tract with un­named phar­ma; Rentschler's new build

Anna Brown

News Reporter

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Lon­za said it has

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CRISPR ther­a­py re­duces swelling at­tacks by 81% in In­tel­lia fol­low-up study

Roche re­turns to Dyno for its AAV tech with $50M up­front

Ex­clu­sive: Uni­ver­si­ty of Toron­to spin­out rais­es $53.5M to cre­ate new obe­si­ty drugs with AI

Zai Lab un­veils ear­ly lung can­cer da­ta as it looks to chal­lenge Am­gen's Imdell­tra

Ex­clu­sive: Moldo­va clears first gene edit­ing study for HBV in hu­mans

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times